Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS
Year: 2014
Type: article
Abstract: Glucocorticoids are normally regarded as anti-inflammatory therapy for a wide variety of conditions and have been used with some success in treating sepsis and sepsis-like syndromes. We previously demonstrated that mice lacking the glucocorticoid receptor in the endothelium (GR EC KO mice) are extremely sensitive to low-dose LPS and demonstrate prolonged activation and up regulation of NF-κB. In this study we pre-treated these GR EC KO mice with dexamethasone and assessed their response to an identical dose of LPS. Surprisingly, the GR EC KO mice fared even worse than when given LPS alone demonstrating increased mortality, increased levels of the inflammatory cytokines TNF-α and IL-6 and increased nitric oxide release after the dexamethasone pre-treatment. As expected, control animals pre-treated with dexamethasone showed improvement in all parameters assayed. Mechanistically we demonstrate that GR EC KO mice show increased iNOS production and NF-κB activation despite treatment with dexamethasone.
Source: PLoS ONE
Institutions: Yale University, VA Connecticut Healthcare System
Language: English
Topic: NF-κB Signaling Pathways
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,382
Awards: G1912008454, microRNA regulation of endothelial functions, Phosphorylation and Endothelial Nitric Oxide Production, Regulation of vascular remodeling & angiogenesis by Nogo, Yale Mouse Metabolic Phenotyping Center, The Role of Vascular Smooth Muscle GR in Acute Glucocorticoid-mediated HTN, Endothelial NOS by Protein-Protein Intractions, Molecular Mechanisms of Arterigenesis, George M. O'Brien Kidney Center at Yale, Endothelial NOS by protein to protein interactions, G9000097746
OpenAlex ID: W1987467309
